Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EGF Ointment for Erlotinib-Related Skin Effects
NCT01593995Phase 2Completed
- Start
- May 2012
- Primary completion
- Dec 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of nepidermin in drug eruption. Primary endpoint: Improvement of skin lesion grading by NCI-CTC v3.0 at 4 weeks. Started May 2012; status: completed.
02
Drugs
nepidermin
03
Conditions
drug eruption
Beyond the preview
Go deeper on NCT01593995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01593995.